This RSS feed URL is deprecated
Worth Watching Healthcare Stock: Arbutus Biopharma Corporation (ABUS) - Stock Digest (press release)
Arbutus Biopharma Corporation (ABUS):. Checking on recent price levels compared to prior highs and lows, we have seen that Arbutus Biopharma Corporation (ABUS) recently traded -65.79% away from the 50-day high and moved 6.16% from the 50-day ...altro »
Benzinga's Top Upgrades, Downgrades For October 16, 2018 - Benzinga
Government Properties Income Trust shares rose 1.8 percent to $10.00 in pre-market trading. B. Riley upgraded Arbutus Biopharma Corp (NASDAQ: ABUS) from Neutral to Buy. Arbutus Biopharma shares fell 3.94 percent to close at $4.14 on Monday.altro »
Stocks to Forgive and Forget and Buy: Arbutus Biopharma Corporation (ABUS), 3M Company (MMM) - GV Times
Arbutus Biopharma Corporation (ABUS) trade volume has increased by 630.44% as around 3,423,754 shares were sold when compared with its 50-day average volume of traded shares which is 468,722. At the moment, ABUS is witnessing a downtrend, as it ...
Arbutus Biopharma Corp (NASDAQ:ABUS) gets upgraded to Buy by B. Riley with a price target of $9.00 - Market Exclusive
Analyst Ratings For Arbutus Biopharma Corp (NASDAQ:ABUS). Today, Arbutus Biopharma Corp (NASDAQ:ABUS) stock received an upgrade by B. Riley from Neutral to Buy with a price target of $9.00. There are 3 Hold Ratings, 2 Buy Ratings, no Strong Buy ...altro »
Stock within Analysts Limelight: Arbutus Biopharma Corporation (ABUS) - Nasdaq Click (press release)
Arbutus Biopharma Corporation (ABUS) stock price ended its day with gain 4.87% and finalized at the price of $4.31, its 52 week- peak value and changed 6.16% from its 52 week-bottom price value. During its last trading session, Stock traded with the ...
Hot Condition Now? Arbutus Biopharma Corporation (ABUS) - NYSE DAILY (press release)
Arbutus Biopharma Corporation (ABUS) exchanged 631301 shares on hands in most recent trading session and observed an average volume with 511.25K shares. The stock acknowledged active focus on shares in the Friday trading session. ABUS ...altro »
EPS for Arbutus Biopharma Corporation (ABUS) Expected At $-0.40 - Thorold News
After having $-0.44 EPS previously, Arbutus Biopharma Corporation's analysts see -9.09 % EPS growth. The stock decreased 3.94% or $0.17 during the last trading session, reaching $4.14. About 534,735 shares traded or 12.25% up from the average.
Analysts Call Attention:: Arbutus Biopharma Corporation, (NASDAQ: ABUS), The Progressive Corporation, (NYSE: PGR) - Nyse Trading News (press release)
Intraday Trading of Arbutus Biopharma Corporation: The Healthcare stock finished its last trading at $6 while performed a change of -33.99% on Tuesday. Arbutus Biopharma Corporation, a Canada based Company, belongs to Healthcare sector and ...altro »
Arbutus Biopharma Corp (ABUS) Anticipated to Post Quarterly Sales of $230000.00 - BharataPress
Wall Street analysts predict that Arbutus Biopharma Corp (NASDAQ:ABUS) will announce $230,000.00 in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Arbutus Biopharma's earnings ...
Arbutus Biopharma Corporation (ABUS)- Safe Haven Performance Portfolio Stocks - NASDAQ Times
Arbutus Biopharma Corporation (NASDAQ:ABUS) apart from individual factors many macro and micro factors also affects in different manner to the whole sector and industries. Shares jumped down -23.83% to trade at $4.57 in the last beat. By excluding ...altro »